Study: OTC stomach meds trigger upset

Share this article:

Consumers are paying attention to OTC side effects. A study by research firm Mintel indicates that 38% of consumers with gastrointestinal issues are worried about the impact some of these medications can have on health.

The firm noted that while antacid and laxative sales dropped 2.5% between 2011 and 2013, 29% of stomach-centric shoppers say they have been adopting strategies such as eating more yogurt and fiber-rich foods to limit symptoms.

Mintel said its research does not mean OTC stomach remedy sales are destined to idle. Mintel health and wellness analyst Emily Krol said in a statement that brands can meet consumer concerns through strategies that position their products “as part of an overall healthy lifestyle.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.